| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.32 | 3e-10 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.29 | 1e-07 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.22 | 3e-05 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |